Senior Vice President & Chief Scientific Officer (Retired) Warner-Lambert Company – Ann Arbor, Michigan
Dr. Ronald M. Cresswell was named President of the Worldwide Pharmaceutical Research and Development Division of Warner-Lambert Company in 1988. At that time, he was also elected to Warner-Lambert’s Board of Directors as Vice President and an officer of the corporation. One year later, he was named Chairman of the division, now known as Parke-Davis Pharmaceutical Research, a position he held until 1998. From 1998 until his retirement in late 1999, Dr. Cresswell served as Senior Vice President and Chief Scientific Officer of Warner-Lambert Company. Warner-Lambert is a worldwide company devoted to developing, manufacturing and marketing quality health care and consumer products. It employs more than 40,000 people. The company’s largest research facility is located in Ann Arbor, Michigan. Additional research facilities are operated in several other countries, including major centers in Cambridge, England; Fresnes, France; and Freiburg, Germany. Prof. Cresswell joined Warner-Lambert from Laporte Industries, Ltd., London, an internationally oriented chemical company, where he served as chief operating officer since 1987. Prior to joining Laporte, Prof. Cresswell was associated with the London-based international pharmaceutical firm Burroughs Wellcome Company for 25 years, 19 of which were spent in its U.S. research and development organization. His career at Burroughs Wellcome included a broad range of research and development positions, culminating with his responsibility for the company’s worldwide research staff of 3,000 people. Prof. Cresswell earned B.Sc. and Ph.D. degrees in applied chemistry at the University of Glasgow. He completed post-doctoral work in the field of nucleoprotein chemistry at Sloan Kettering Hospital in New York, and is a graduate of the Harvard Advanced Management Program. In July 1997 Prof. Cresswell was awarded an Honorary Degree of Doctor of Science at The University of Strathclyde in Glasgow.